161 related articles for article (PubMed ID: 36629999)
1. Decreased natural killer T-like cells correlated to disease activity in systemic lupus erythematosus.
Tang S; Wang Y; Ma X; Xiang X; Zhou X; Li Y; Jia Y; Hu F; Li Y
Clin Rheumatol; 2023 May; 42(5):1435-1442. PubMed ID: 36629999
[TBL] [Abstract][Full Text] [Related]
2. Natural Killer and Natural Killer T Cells in Juvenile Systemic Lupus Erythematosus: Relation to Disease Activity and Progression.
Zahran AM; Abdel-Rahim MH; Elsayh KI; Hassanien MM; Mahran SA; Hetta HF
Arch Immunol Ther Exp (Warsz); 2019 Jun; 67(3):161-169. PubMed ID: 30944972
[TBL] [Abstract][Full Text] [Related]
3. Increased ILT2
Chen N; Dai Y; Li H; Long X; Ke J; Zhang J; Sun H; Gao F; Lin H; Yan Q
Clin Rheumatol; 2023 Nov; 42(11):3113-3121. PubMed ID: 37695380
[TBL] [Abstract][Full Text] [Related]
4. Effect of Interleukin-15 on CD11b, CD54, and CD62L Expression on Natural Killer Cell and Natural Killer T-Like Cells in Systemic Lupus Erythematosus.
Lin SJ; Chen JY; Kuo ML; Hsiao HS; Lee PT; Huang JL
Mediators Inflamm; 2016; 2016():9675861. PubMed ID: 27847409
[TBL] [Abstract][Full Text] [Related]
5. Changes of frequency and expression level of CD161 in CD8
Park Y; Lim J; Kim SY; Kwon GC; Koo SH; Kim J
Microbiol Immunol; 2020 Jul; 64(7):532-539. PubMed ID: 32343447
[TBL] [Abstract][Full Text] [Related]
6. [Role of circulating T follicular helper subsets and T follicular helper effector memory cells in systemic lupus erythematosus].
Liang YC; Yao Y; Zhang RJ; Shao M; Sun XL; Shi GX; Gao C; Yu D; He J
Zhonghua Yi Xue Za Zhi; 2019 Jan; 99(3):164-168. PubMed ID: 30669756
[No Abstract] [Full Text] [Related]
7. Assay of T- and NK-cell subsets and the expression of NKG2A and NKG2D in patients with new-onset systemic lupus erythematosus.
Li WX; Pan HF; Hu JL; Wang CZ; Zhang N; Li J; Li XP; Xu JH; Ye DQ
Clin Rheumatol; 2010 Mar; 29(3):315-23. PubMed ID: 20012119
[TBL] [Abstract][Full Text] [Related]
8. Changes in immune cell frequencies after cyclophosphamide or mycophenolate mofetil treatments in patients with systemic lupus erythematosus.
Zhao L; Jiang Z; Jiang Y; Ma N; Wang K; Zhang Y
Clin Rheumatol; 2012 Jun; 31(6):951-9. PubMed ID: 22349930
[TBL] [Abstract][Full Text] [Related]
9. Activation status of CD56
Liu M; Liu J; Zhang X; Xiao Y; Jiang G; Huang X
Clin Rheumatol; 2021 Mar; 40(3):1103-1112. PubMed ID: 32797360
[TBL] [Abstract][Full Text] [Related]
10. Natural killer T cells in families of patients with systemic lupus erythematosus: their possible role in regulation of IGG production.
Green MR; Kennell AS; Larche MJ; Seifert MH; Isenberg DA; Salaman MR
Arthritis Rheum; 2007 Jan; 56(1):303-10. PubMed ID: 17195234
[TBL] [Abstract][Full Text] [Related]
11. CD56brightCD16- to CD57+CD56dimCD16+ NK cell ratio discriminates disease activity and renal involvement in patients with systemic lupus erythematosus.
Li H; Geng L; Cao Z; Jin Z; Yan Q; Long X; Zhang X; Meng D; Jiang Y; Li W; Sun L
Clin Exp Rheumatol; 2023 Sep; 41(9):1768-1776. PubMed ID: 36826804
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of natural killer cells and of gamma/delta T cells in systemic lupus erythematosus. Does it correlate to autoimmunity and to laboratory indices of disease activity?
Riccieri V; Spadaro A; Parisi G; Taccari E; Moretti T; Bernardini G; Favaroni M; Strom R
Lupus; 2000; 9(5):333-7. PubMed ID: 10878724
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the CD161-expressing cell quantities and CD161 expression levels in peripheral blood natural killer and T cells of systemic lupus erythematosus patients.
Lin YL; Lin SC
Clin Exp Med; 2017 Feb; 17(1):101-109. PubMed ID: 26590595
[TBL] [Abstract][Full Text] [Related]
14. Chemokine CXCL1 as a potential marker of disease activity in systemic lupus erythematosus.
Zeng Y; Lin Q; Yu L; Wang X; Lin Y; Zhang Y; Yan S; Lu X; Li Y; Li W; Xiao Y
BMC Immunol; 2021 Dec; 22(1):82. PubMed ID: 34961474
[TBL] [Abstract][Full Text] [Related]
15. Numerical and functional deficiencies of natural killer T cells in systemic lupus erythematosus: their deficiency related to disease activity.
Cho YN; Kee SJ; Lee SJ; Seo SR; Kim TJ; Lee SS; Kim MS; Lee WW; Yoo DH; Kim N; Park YW
Rheumatology (Oxford); 2011 Jun; 50(6):1054-63. PubMed ID: 21278064
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of natural killer activating and inhibitory receptors in patients with newly diagnosed systemic lupus erythematosus.
Ye Z; Ma N; Zhao L; Jiang ZY; Jiang YF
Int J Rheum Dis; 2016 Jun; 19(6):613-21. PubMed ID: 24617980
[TBL] [Abstract][Full Text] [Related]
17. Anti-dsDNA, anti-nucleosome, anti-C1q, and anti-histone antibodies as markers of active lupus nephritis and systemic lupus erythematosus disease activity.
Shang X; Ren L; Sun G; Yu T; Yao Y; Wang L; Liu F; Zhang L; He X; Liu M
Immun Inflamm Dis; 2021 Jun; 9(2):407-418. PubMed ID: 33470559
[TBL] [Abstract][Full Text] [Related]
18. Anti-dsDNA, anti-nucleosome and anti-C1q antibodies as disease activity markers in patients with systemic lupus erythematosus.
Zivković V; Stanković A; Cvetković T; Mitić B; Kostić S; Nedović J; Stamenković B
Srp Arh Celok Lek; 2014; 142(7-8):431-6. PubMed ID: 25233687
[TBL] [Abstract][Full Text] [Related]
19. Nonrenal and renal activity of systemic lupus erythematosus: a comparison of two anti-C1q and five anti-dsDNA assays and complement C3 and C4.
Julkunen H; Ekblom-Kullberg S; Miettinen A
Rheumatol Int; 2012 Aug; 32(8):2445-51. PubMed ID: 21706294
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of the phosphatase JKAP/DUSP22 in T cells as a potential new biomarker of systemic lupus erythematosus nephritis.
Chuang HC; Chen YM; Hung WT; Li JP; Chen DY; Lan JL; Tan TH
Oncotarget; 2016 Sep; 7(36):57593-57605. PubMed ID: 27557500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
